Meeting
Abstract Number: 72
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Recent guidelines include aspirin as an option to prevent venous thromboembolism (VTE) in selected patients undergoing hip or knee replacement surgery. However, the efficacy of aspirin after arthroplasty has not been well-defined, particularly in more contemporary patient populations. Objective: To compare rates of post-operative VTE between patients who received aspirin-only versus anticoagulants after hip […]
Abstract Number: 129
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Over 6 million people in the US have a diagnosis of atrial fibrillation. Given the increased risk for stroke and systemic embolism, many patients are treated with direct oral anticoagulants (DOACs) to reduce their risk. In the major trials comparing to DOACs to warfarin for stroke and systemic embolism prevention in atrial fibrillation, DOACs […]
Abstract Number: 148
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: The role of aspirin in primary prevention of cardiovascular events remains controversial, Especially in diabetic patients. We have conducted a meta-analysis of all randomized controlled trials (RCTs) to evaluate the efficacy and safety of aspirin for primary prevention in diabetic patients. Methods: Literature search of Pubmed, MEDLINE, Cochrane Library and Clinicaltrials.gov for related RCTs […]
Abstract Number: 187
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Worldwide, 200 million adults undergo non-cardiac surgery annually, and completing pre-operative assessments is a major role of today’s hospitalists. In previous years, decisions regarding anti-platelet agents were less evidence-based and often fell to provider preference. With the release of POISE-2 in 2014, there is now stronger evidence to support holding aspirin before elective surgery […]